Alteration of tissue oxygen partial pressure during isolated, hyperthermic limb perfusion with cytostatic drugs or recombinant human tumor necrosis factor alpha combined with melphalan.
Hohenberger
P
P
Division of Surgery and Surgical Oncology Robert-Rössle Hospital, Berlin. hohenberger@rrk-berlin.de
Bida
B
B
Schlag
P M
PM
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols; D010478:Chemotherapy, Cancer, Regional Perfusion; D005121:Extremities; D006801:Humans; D006979:Hyperthermia, Induced; D008297:Male; D008545:Melanoma / Q000378:metabolism* / Q000628:therapy*; D008558:Melphalan / Q000008:administration & dosage*; D008875:Middle Aged; D010100:Oxygen / Q000032:analysis* / Q000378:metabolism; D010313:Partial Pressure; D011048:Polarography; D012509:Sarcoma / Q000188:drug therapy / Q000378:metabolism* / Q000628:therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D014409:Tumor Necrosis Factor-alpha; D008558:Melphalan; D010100:Oxygen